drugset / Trial / NCT00210054

A Pharmacokinetic Evaluation Study in Healthy Volunteers

NCT00210054 ↗

Phase 1 Completed 4 enrolled Merck Sharp & Dohme LLC
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this trial is to characterize the pharmacokinetics of INS37217 following intravenous administration.

Timeline

Start
2002-11
Primary completion
2002-12
Completion
2002-12

Drugs

EvaluationDrugModalityDoseRoute
Subject denufosol Other / unclassified — Intravenous

Indications

No indication recorded.